Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy?
Chase DM, Fedewa S, Chou TS, Chen A, Ward E, Brewster WR.
Obstet Gynecol. 2012 Jan;119(1):68-77.
Related citations
Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity.
Romero IL, McCormick A, McEwen KA, Park S, Karrison T, Yamada SD, Pannain S, Lengyel E.
Obstet Gynecol. 2012 Jan;119(1):61-7.
Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening.
van Nagell JR Jr, Miller RW, DeSimone CP, Ueland FR, Podzielinski I, Goodrich ST, Elder JW, Huang B, Kryscio RJ, Pavlik EJ.
Obstet Gynecol. 2011 Dec;118(6):1212-21.
Can ovarian cancer screening save lives? The question remains unanswered.
Jacobs I, Menon U.
Obstet Gynecol. 2011 Dec;118(6):1209-11. No abstract available.
Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.
Timmerman D, Van Calster B, Vergote I, Van Hoorde K, Van Gorp T, Valentin L, Bourne T.
Obstet Gynecol. 2011 Nov;118(5):1179-81; author reply 1181. No abstract available.
Sawaya GF, Jacoby V.
Obstet Gynecol. 2011 Nov;118(5):1178; author reply 1178-9. No abstract available.
Management of the adnexal mass.
Ricci G, Zito G, Fischer-Tamaro L.
Obstet Gynecol. 2011 Oct;118(4):956; author reply 956-7. No abstract available.
Involvement of gynecologic oncologists in the treatment of patients with a suspicious ovarian mass.
Goff BA, Miller JW, Matthews B, Trivers KF, Andrilla CH, Lishner DM, Baldwin LM.
Obstet Gynecol. 2011 Oct;118(4):854-62.
Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly.
Thrall MM, Goff BA, Symons RG, Flum DR, Gray HJ.
Obstet Gynecol. 2011 Sep;118(3):537-47.
Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy.
Plusquin C, Vandromme J, Fastrez M, Rozenberg S.
Obstet Gynecol. 2011 Aug;118(2 Pt 1):359; author reply 359-60. No abstract available.
Error occurred: cannot get document summary
Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass.
Moore RG, Miller MC, Disilvestro P, Landrum LM, Gajewski W, Ball JJ, Skates SJ.
Obstet Gynecol. 2011 Aug;118(2 Pt 1):280-8.
Pelvic Salmonella infection masquerading as gynecologic malignancy.
Kudesia R, Gupta D.
Obstet Gynecol. 2011 Aug;118(2 Pt 2):475-7.
Liu JH, Zanotti KM.
Obstet Gynecol. 2011 Jun;117(6):1413-28. Review.
Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.
Ueland FR, Desimone CP, Seamon LG, Miller RA, Goodrich S, Podzielinski I, Sokoll L, Smith A, van Nagell JR Jr, Zhang Z.
Obstet Gynecol. 2011 Jun;117(6):1289-97.
Ware Miller R, Smith A, DeSimone CP, Seamon L, Goodrich S, Podzielinski I, Sokoll L, van Nagell JR Jr, Zhang Z, Ueland FR.
Obstet Gynecol. 2011 Jun;117(6):1298-306.
Vitonis AF, Titus-Ernstoff L, Cramer DW.
Obstet Gynecol. 2011 May;117(5):1042-50.
Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer.
American College of Obstetricians and Gynecologists Committee on Gynecologic Practice.
Obstet Gynecol. 2011 Mar;117(3):742-6.
Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer.
Blank SV.
Obstet Gynecol. 2011 Feb;117(2 Pt 1):404; author reply 404. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on